A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This study evaluates how a drug that alters liver enzymes (rifampin) affects the metabolism
of enzalutamide in men by measuring concentrations of enzalutamide and its metabolites in
plasma.